{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:11:28Z","timestamp":1793293888339,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10338-8","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T03:59:33Z","timestamp":1736827173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022"],"prefix":"10.1186","volume":"25","author":[{"given":"Sharifa Ezat","family":"WP","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Norhidayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8162-1380","authenticated-orcid":false,"given":"Muhammad Nur Amir","family":"AR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"10338_CR1","doi-asserted-by":"crossref","unstructured":"Liew KC, O\u2019Keeffe J, Rajandas H, Lee YPH, Parimannan O, Croft S, Athan L. E. Insights into the Evolution of P. aeruginosa Antimicrobial Resistance in a Patient Undergoing Intensive Therapy. Antibiotics. 2023.","DOI":"10.3390\/antibiotics12030483"},{"key":"10338_CR2","unstructured":"About Antimicrobial CDC. Resistance2024. https:\/\/www.cdc.gov\/antimicrobial-resistance"},{"key":"10338_CR3","unstructured":"Murray CJLea. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. 2022."},{"key":"10338_CR4","unstructured":"ECDC. Facts about antimicrobial resistance2024. https:\/\/www.ecdc.europa.eu\/en\/antimicrobial-resistance\/facts"},{"key":"10338_CR5","doi-asserted-by":"crossref","unstructured":"Song C-J, Kim N-K, Choi J, Ahn PG, Choe, Park WB et al. Clinical and economic burden of bacteremia due to multidrug-resistant organisms in Korea: a prospective case control study. J Global Antimicrob Resist. 2022.","DOI":"10.1016\/j.jgar.2022.11.005"},{"key":"10338_CR6","doi-asserted-by":"crossref","unstructured":"Reygaert. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018.","DOI":"10.3934\/microbiol.2018.3.482"},{"key":"10338_CR7","unstructured":"KKM. HEALTH INDICATORS 2023. 2023."},{"key":"10338_CR8","unstructured":"IHME. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. 2022."},{"key":"10338_CR9","doi-asserted-by":"crossref","unstructured":"Barrasa-Villar JI. Carlos Aibar-Rem\u00f3n, Purificaci\u00f3n Prieto-Andr\u00e9s, Rosa Mareca-Do\u00f1ate, Moliner-Lahoz J. Impact on Morbidity, Mortality, and Length of Stay of Hospital-Acquired Infections by Resistant Microorganisms. Infectious Disease Society of America. 2017.","DOI":"10.1093\/cid\/cix411"},{"key":"10338_CR10","doi-asserted-by":"crossref","unstructured":"Hay PC, Rao C, Dolecek, Nicholas PJ, Day A, Stergachis, Lopez AD et al. Measuring and mapping the global burden of antimicrobial resistance. BMC Med. 2018.","DOI":"10.1186\/s12916-018-1073-z"},{"key":"10338_CR11","doi-asserted-by":"crossref","unstructured":"Vered Schechner L, Wulffhart E, Temkin SF, Feldman A, Nutman P, Shitrit et al. One-year mortality and years of potential life lost following bloodstream infection among adults: A nation-wide population based study. The Lancet Regional Health - Europe. 2022;23: 100511. 2022.","DOI":"10.1016\/j.lanepe.2022.100511"},{"key":"10338_CR12","unstructured":"CDC. About HAIs. 2024."},{"key":"10338_CR13","unstructured":"Cekin Z, Ahsen Oncul BB. Bloodstream Infections Caused by Multidrug Resistant Bacteria: Clinical and Microbiological Features and Mortality. The Medical Bulletin of Sisli Etfal Hospital; 2023."},{"key":"10338_CR14","doi-asserted-by":"crossref","unstructured":"Friedman ND, Levit D, Taleb E, Marcus G, Michaeli L, Broide M, et al. Towards a Definition for Health Care\u2013Associated Infection. Open Forum Infectious Diseases; 2018.","DOI":"10.1093\/ofid\/ofy116"},{"key":"10338_CR15","doi-asserted-by":"crossref","unstructured":"Friedrich AW. Control of hospital acquired infections and antimicrobial resistance in Europe. Wien Med Wochenschr. 2019.","DOI":"10.1007\/s10354-018-0676-5"},{"key":"10338_CR16","unstructured":"Prevention CDCMDRO. and Control2024. https:\/\/www.cdc.gov\/infection-control\/hcp\/mdro-management\/prevention-control.html"},{"key":"10338_CR17","doi-asserted-by":"crossref","unstructured":"Al-Sunaidar KA, Mahendran Sekar NA, Aziz Y, Hassan, Jamshed S. Association of Multidrug Resistance Bacteria and Clinical Outcomes of Adult Patients with Sepsis in the Intensive Care Unit. Tropical Medicine and Infectious Disease; 2022.","DOI":"10.20944\/preprints202209.0326.v1"},{"key":"10338_CR18","doi-asserted-by":"crossref","unstructured":"Sumardika IW, Frederick Cokro IW, Suranadi, Pinatih KJP. Multidrug-Resistant Organism Infections Correlate with Increased Mortality in COVID-19 Patients: A Retrospective, Observational Cohort Study. Bali J Anesthesiology. 2022.","DOI":"10.4103\/bjoa.bjoa_181_22"},{"key":"10338_CR19","doi-asserted-by":"crossref","unstructured":"Ibrahim ME. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Ann Clin Microbiol Antimicrob. 2019.","DOI":"10.1186\/s12941-018-0301-x"},{"key":"10338_CR20","doi-asserted-by":"crossref","unstructured":"Chen C-H, Lin L-C 1, Chen Y-JCY-M, Huang C-YC. C-C. Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for Institutes. International Journal of Environmental Research and Public Health. 2015.","DOI":"10.3390\/ijerph120808871"},{"key":"10338_CR21","unstructured":"KKM. Multidrug Organism Surveillance Manual. 2018."},{"key":"10338_CR22","doi-asserted-by":"crossref","unstructured":"Howard A, O\u2019Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii. PibMed Cent. 2012.","DOI":"10.4161\/viru.19700"},{"key":"10338_CR23","doi-asserted-by":"crossref","unstructured":"Li Huang J, Tang G, Tian H, Tao, Li Z. Risk Factors, Outcomes, and Predictions of Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Infections in Patients with Nervous System Diseases. Infection and Drug Resistance; 2023.","DOI":"10.2147\/IDR.S439241"},{"key":"10338_CR24","unstructured":"KKM. Infection Control and Antimicrobial Resistance (AMR) Antimicrobial Surveillance Programme Annual Report 2022. 2023."},{"key":"10338_CR25","unstructured":"KKM MAFI. Malaysian Action Plan on Antimicrobial Resistance (MyAP-AMR) 2022\u20132026. 2022."},{"key":"10338_CR26","doi-asserted-by":"crossref","unstructured":"Santoro A, Erica Franceschini M, Meschiari M, Menozzi S, Zona C, Venturelli et al. Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria. Open Forum Infect Dis. 2020.","DOI":"10.1093\/ofid\/ofaa461"},{"key":"10338_CR27","doi-asserted-by":"crossref","unstructured":"Banerjee T, AnwitaMishra A, Das S, Sharma, HiranmayBarman Y, aG. High Prevalence and Endemicity ofMultidrug Resistant Acinetobacter spp. in Intensive Care Unit of a Tertiary Care Hospital, Varanasi, India. J Pathogens. 2018;2018, Article ID 9129083, 8 pages.","DOI":"10.1155\/2018\/9129083"},{"key":"10338_CR28","doi-asserted-by":"crossref","unstructured":"Lim Cherry HV, Klaytong P, Rangsiwutisak C, Tangwangvivat R, Phiancharoen C et al. Frequency and mortality rate following antimicrobial-resistant bloodstream infections in tertiary-care hospitals compared with secondary-care hospitals. PLoS ONE. 2024.","DOI":"10.1101\/2023.02.07.23285611"},{"key":"10338_CR29","doi-asserted-by":"crossref","unstructured":"Maia CD et al. Gomes da Silveira, Maura Gomes, S\u00e9rgio Eduardo Soares Fernandes, Ros\u00e1lia Bezerra de Santana, Daniella Queiroz de Oliveira,. Multidrug-Resistant Bacteria on Critically Ill Patients with Sepsis at Hospital Admission Risk Factors and Effects on Hospital Mortality. Infection and Drug Resistance. 2023.","DOI":"10.2147\/IDR.S401754"},{"key":"10338_CR30","doi-asserted-by":"crossref","unstructured":"Alsehemi AF, Emad A, Alharbi BB, Alammash AI, Alrais HM, Elbadawy, Alahmadi YM. Assessment of risk factors associated with multidrug-resistant organism infections among patients admitted in a tertiary hospital a retrospective study. Saudi Pharm J. 2023.","DOI":"10.1016\/j.jsps.2023.03.019"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10338-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10338-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10338-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:36:12Z","timestamp":1762342572000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10338-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10338"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10338-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5028553\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics clearance and approval were obtained from the Medical Research and Ethics Committee (MREC) of the Ministry of Health Malaysia [NMRR ID-23-01759-ZOY (IIR)] and the Research Ethics Committee from the National University of Malaysia [UKM PPI\/111\/8\/JEP-2023-201] prior to the conduct of this study. We also obtain permission from the Director of Medical Development Division, Ministry of Health Malaysia who is the custodian of the data required for this study. The assigned healthcare personnel obtained informed consent from patients prior to initiating data collection at the hospital level, ensuring that individuals are fully aware of the purpose, process, and potential implications of their participation. Patient names were kept on a password-protected database and were linked only with a study identification number. All the data involved in this study are restricted to use by the investigator.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}